Fred Alger Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,681
| Closed | -$2.27M | – | 444 |
|
|
2025
Q1 | $2.27M | Buy |
25,681
+58
| +0.2% | +$5.13K | 0.01% | 291 |
|
|
2024
Q4 | $2.23M | Sell |
25,623
-7,487
| -23% | -$653K | 0.01% | 321 |
|
|
2024
Q3 | $3.06M | Sell |
33,110
-15,478
| -32% | -$1.43M | 0.01% | 291 |
|
|
2024
Q2 | $5.24M | Buy |
48,588
+31,675
| +187% | +$3.41M | 0.03% | 238 |
|
|
2024
Q1 | $1.6M | Buy |
+16,913
| New | +$1.6M | 0.01% | 356 |
|
|
2018
Q4 | – | Sell |
-8,000
| Closed | -$624K | – | 521 |
|
|
2018
Q3 | $624K | Sell |
8,000
-500
| -6% | -$39K | ﹤0.01% | 345 |
|
|
2018
Q2 | $540K | Buy |
8,500
+3,000
| +55% | +$191K | ﹤0.01% | 356 |
|
|
2018
Q1 | $504K | Buy |
+5,500
| New | +$504K | ﹤0.01% | 370 |
|
|
2017
Q4 | – | Sell |
-8,000
| Closed | -$557K | – | 564 |
|
|
2017
Q3 | $557K | Buy |
8,000
+4,000
| +100% | +$279K | ﹤0.01% | 350 |
|
|
2017
Q2 | $203K | Buy |
+4,000
| New | +$203K | ﹤0.01% | 390 |
|